Imagin Medical Inc. (IMEXF)

[Money $hot]

Endoscopy Market to Rise US$ 41.0 billion by 2024

Jan 29, 2019 (Heraldkeeper via COMTEX) -- New York, January 29, 2019: The scope of the report includes a detailed study of global and regional markets for Global Endoscopy Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Olympus Corporation, Ethicon (Johnson & Johnson), Karl Storz GmbH, Boston Scientific, Inc., CovidienPlc, Stryker Corporation, Hoya Corporation (Pentax Medical System), Cook Medical Incorporated, Conmed Corporation, Fujifilm Holding Corporation, Smith and Nephew, Inc., and Richard Wolf GmbH.. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Global Endoscopy Market is expected to exceed more than US$ 41.0 billion by 2024 and will grow at a CAGR of more than 6% in the given forecast period.

https://www.marketwatch.com/press-release/endoscopy-market-to-rise-us-410-billion-by-2024-2019-01-29

Jim Hutchens explained the 400M-800M was only 2 surgical areas of the overall market Imagin is targeting first. Click Here To See Growth Strategy on Pg 13 of PowerPoint Presentation. Imagin Medical's equipment adapts to endoscopic equipment across the board. Meaning the entire market is in our sight/scope - pun intended. Furthermore, your math is woefully inadequate. The current Outstanding shares is 140 million shares. If Imagin sold for $40M to $80M as you suggest, that breaks down to .285 cent - .57 cent per share. No 7Card. Nobody is here for a return of 58 friggin cents! My math is correct. Stop thinking small...think big in pennyland...or you will be stuck in Pennyland forever my friend.

CRASH COURSE:

"Now I want to emphasize, we don't sell endoscopes. Like the company you've all heard of Olympus is a big German company that sells endoscopes, that's not what we do. We sell our equipment and we adapt to all of the different endoscopes that are on the market."

Hence, our equipment adds significant value to the 41 Billion dollar Endoscopy Market.

BREAKING DOWN Comps

Also known as comparable same-store sales, the comps metric is used by analysts and investors to determine what portion of sales growth is attributed to old stores compared to new stores. Some large retail chains release comps on a monthly basis.

https://www.investopedia.com/terms/c/comps.asp

Jim Hutchens @ 12:13

This is a company named Novadaq that was sold to Stryker, and they had a white light IGC type flourecent endoscopic system. So did Stryker. They had a visualization of blood flow and tissue profusion during the surgery. So did Stryker. They had the ability to manipulate the images. Make it practical for the doctor. They did not. Stryker bought Novadaq for 701 Million Dollars

http://noble.mediasite.com/Mediasite/Play/14eeb5b989c64caea92d4f2b2217592a1d

The point "General" Jim Hutchens is making regarding comps - Imagin's technology will be a target of the BIG BOYS as they try to one up each other. I see a feeding frenzy bidding war on the horizon.


/////AMG

P.S. There's nothing more irking than sharing thoughtful DD, only to get slapped @ with nonsensical one-liners. Maybe one should DYODD